Post

AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial

AstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did not improve overall survival (OS) …

Spyre Therapeutics doses first subjects in Phase I IBD treatment trial

Spyre Therapeutics has dosed the first subjects in the Phase I clinical trial of SPY001 to potentially treat inflammatory bowel …

Medidata introduces new AI-powered platform for clinical trials

Medidata has introduced Clinical Data Studio, an AI-powered platform that aims to transform the clinical research data experience to streamline …

Europe updates CTIS to support more transparent trial reporting

The EMA has removed the ability for sponsors to defer trial data for seven years in a transparency update to …

Autonomix shares positive data from transvascular RF ablation trial

Texas-based device company Autonomix Medical has announced preliminary positive results from the proof-of-concept clinical trial evaluating transvascular radiofrequency (RF) ablation …